STOCK TITAN

GALEXXY HLDGS INC - GXXY STOCK NEWS

Welcome to our dedicated page for GALEXXY HLDGS news (Ticker: GXXY), a resource for investors and traders seeking the latest updates and insights on GALEXXY HLDGS stock.

Galexxy Holdings Inc. (OTC PINK: GXXY) is a diversified company with a focus on emerging markets. They have expanded their strategic commercial supply and lease agreements, marketing programs, and installations of smart kiosks. The company works closely with Delta 88 and uVending, aiming to generate substantial revenues in the coming years. Galexxy is known for its innovative geospatial advertising solutions and proprietary products, driving foot traffic and sales through VendGenie Smart Kiosks.

Recently, Galexxy has appointed Trent D'Ambrosio as the Vice President of Sales and Marketing. With a successful background in executive business management and sales, Trent is expected to drive rapid sales revenue growth and expand retail and wholesale sales programs. Galexxy is set to launch the Galexxy Sales App, integrating Verb and Hussle technologies, to empower sales leaders and scale sales organizations through advanced features like live streaming, training, and one-click sampling.

The company is redirecting its focus to the Functional Mushroom Market and direct-selling industry, anticipating substantial growth and positioning themselves as industry leaders. Galexxy is dedicated to revolutionizing the health and wellness sector with innovative products and technology-driven solutions, all aimed at maximizing shareholder value and ensuring long-term sustainability.

Funding Adaptin, a new venture in the wellness market, Galexxy Holdings aims to tap into the growing adaptogen market and provide innovative products with transparent compensation plans. With a visionary leadership team and a strategic approach, Adaptin is set to offer unique opportunities to health and wellness enthusiasts and brand advocates, driving innovation and growth in the direct sales landscape.

Rhea-AI Summary

Galexxy Holdings Inc. (OTC: GXXY) announced the appointment of BF Borgers PCAOB to conduct an audit, initiated on January 3, 2023, with completion expected in February. CEO Iain Saul highlighted that the audit's completion is a critical step towards achieving an OTC QX listing and filing a Form 10 with the SEC, laying a foundation for a future NASDAQ up-listing. The company has also reported positive marketing results and anticipates announcements regarding production and international distribution soon. Galexxy operates through its subsidiary Wellbeing Farms in California and has expanded its market presence in natural health supplements since April 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.14%
Tags
none
-
Rhea-AI Summary

Galexxy Holdings (OTC: GXXY) announces a Supply Agreement between its subsidiary Wellbeing Farms LLC and AMM Distributors Inc. This partnership will support the installation of 40 Smart Vending Kiosks in Chicago, equipped with advanced software for age verification, targeting CBD product sales such as gummies, vapes, and tinctures. Projected sales from these kiosks are about $90,000 monthly. If successful, AMM may order over 10,000 kiosks. Wellbeing Farms aims to offer unique CBD and Functional Mushroom products through this initiative.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5%
Tags
none
-
Rhea-AI Summary

Galexxy Holdings Inc. (OTC: GXXY) announced a dual listing on Upstream, a digital exchange aimed at connecting emerging companies with global investors. The decision follows a board meeting and is intended to enhance the company's market presence and minimize the impact of short selling. CEO Iain Saul highlighted the potential of Upstream's blockchain technology to improve trading transparency and investor protections. Galexxy, which focuses on plant-based health supplements, has also recently completed acquisitions to solidify its market position.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.01%
Tags
none
Rhea-AI Summary

Galexxy Holdings (GXXY) announced that its subsidiary, Wellbeing Farms, is expanding its marketing efforts into Europe and the UK. The company has been nominated for a Leading Manufacturer Award at the White Label World Expo in Germany and is showcasing its superfood mushroom-CBD products at the same event in New York. Additionally, Wellbeing is competing for the Innovative Product of the Year award in London in February 2023. The global functional mushroom market is projected to grow at a 9.5% CAGR, driven by increasing demand for health supplements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Galexxy Holdings has secured a $1,000,000 non-dilutive revolving credit line from a related party to launch Wellbeing Farms Inc.'s smart vending kiosks. The company will utilize $400,000 from this initial draw for acquiring kiosks and inventory. Wellbeing Farms plans to deploy thousands of these customized vending machines over the next two years, backed by TCN Vending Machine Co., Ltd, known for its large-scale production capabilities. This partnership and funding strategy aims to mitigate reliance on toxic convertible debt, enhancing growth prospects for Galexxy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.64%
Tags
none
-
Rhea-AI Summary

Galexxy Holdings Inc. (OTC: GXXY) has entered a Strategic Alliance Agreement with eVendco Inc., enabling the supply, installation, and service of smart vending kiosks for its CBD and Functional Mushroom products. The Alliance includes an option for Galexxy to acquire 100% of eVendco, with 20 million GXXY shares issued for the three-year purchase option. eVendco holds exclusive distribution rights in North America with TCN Vending Machine Co. for its vending systems. Galexxy plans to install over 1,000 kiosks in strategic locations within two years, enhancing its market presence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.03%
Tags
Rhea-AI Summary

Galexxy Holdings Inc. (GXXY) has acquired a majority controlling interest in ABC Wholesale Products, LLC for $1 million, consisting of $100,000 in cash and 6 million shares. ABC, known for its AVALOO™ CBD products, anticipates revenues of $1.5 million in 2022, with projections of $3 million for 2023. This acquisition aims to enhance distribution across North America and drive growth for both Galexxy and its recently acquired Wellbeing Farms. The shares involved are restricted for six months, post which further selling limits apply.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.51%
Tags
-
Rhea-AI Summary

Galexxy Holdings Incorporated (OTC: GXXY) announced the appointment of Mr. Iain G. Saul as Chairman and CEO following its acquisition of Wellbeing Farms LLC. Mr. Saul, an experienced businessman, will leverage his expertise in product development and market capitalization to drive growth. His recent financial support and plans for developing unique Functional Mushroom and CBD-Mushroom products highlight a strategic focus on premium CBD markets. Mr. Ross Lyndon-James will transition from CEO but remain involved in company development, including moving from OTC Pink Sheets to an OTC Regulated Market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.91%
Tags
management
-
Rhea-AI Summary

Galexxy Holdings Inc. (OTC: GXXY) has signed a binding Term Sheet to acquire a majority interest in ABC Wholesale LLC, based in Gainesville, Georgia. This acquisition will generate profitable revenues and open access to 11 eastern states through 20 distributors. The deal aligns with Galexxy's expansion strategy, enhancing cross-marketing opportunities with its existing product range from Wellbeing Farms. CEO Ross Lyndon-James emphasized the acquisition's strategic importance, stating it supports the company’s growth trajectory.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.52%
Tags
Rhea-AI Summary

Galexxy Holdings Inc. (OTC: GXXY) has completed the acquisition of WellBeing Farms LLC, a producer of CBD-Functional Mushroom health supplements. GXXY will issue 30 million restricted shares to gain 100% membership interests in WellBeing. The global functional mushroom market is valued at $24.97 billion in 2021, with a projected CAGR of 9.5%. WellBeing's innovative marketing involves outdoor billboards and smart vending kiosks, with plans for nationwide expansion targeting health clubs. The collaboration aims to meet the rising demand for convenient access to health supplements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.56%
Tags

FAQ

What is the current stock price of GALEXXY HLDGS (GXXY)?

The current stock price of GALEXXY HLDGS (GXXY) is $0.0065 as of December 23, 2024.

What is the market cap of GALEXXY HLDGS (GXXY)?

The market cap of GALEXXY HLDGS (GXXY) is approximately 2.8M.

Who is Trent D'Ambrosio and what role does he play at Galexxy Holdings?

Trent D'Ambrosio is the Vice President of Sales and Marketing at Galexxy Holdings. With a successful background in executive business management and sales, Trent leads the sales strategy and execution, focusing on expanding retail and wholesale sales programs.

What is the Galexxy Sales App and how does it benefit sales leaders?

The Galexxy Sales App integrates Verb and Hussle technologies to empower sales leaders with advanced features like live streaming, training, and one-click sampling. It enables rapid scaling of sales organizations and drives engagement and sales growth.

How is Galexxy Holdings repositioning its focus in the market?

Galexxy Holdings is redirecting its resources to the Functional Mushroom Market and direct-selling industry, anticipating substantial growth and positioning themselves as industry leaders. The company is committed to revolutionizing the health and wellness sector with innovative products and technology-driven solutions.

What is Adaptin, and how does it contribute to Galexxy Holdings' growth strategy?

Adaptin is a new company founded by Galexxy Holdings in the wellness market, focusing on the adaptogen market. With a strategic approach and transparent compensation plans, Adaptin offers unique opportunities to health and wellness enthusiasts and brand advocates, driving innovation and growth in the direct sales landscape.

What are the future plans of Galexxy Holdings in terms of market expansion?

Galexxy Holdings aims to tap into the growing adaptogen market through Adaptin and consolidate its position in the Functional Mushroom Market and direct-selling industry. The company is dedicated to providing innovative products and technology-driven solutions, maximizing shareholder value, and ensuring long-term sustainability.

GALEXXY HLDGS INC

OTC:GXXY

GXXY Rankings

GXXY Stock Data

2.79M
187.45M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Newport Beach